This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Article Remove Compounding Remove Documentation Remove Pharmaceutical Companies
article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

JANUARY 9, 2023

This article is the first part of three and covers the first three of nine predictions, here focusing on global healthcare environmental challenges and what they mean for the pharmaceutical industry. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented.

Vaccines 98
Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98
article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.

Documentation 52
Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024